Jeremy A Jones

Address:

159 Rivers Edge Dr, Conway, SC 29526

VIN:

4T3ZK3BB8AU032614

Make:

TOYOTA

Model:

VENZA

Year:

2010

US Patent:

8129499, Mar 6, 2012

Filed:

Jun 15, 2009

Appl. No.:

12/484853

Inventors:

Curtis R. Brandt - Stoughton WI, US
Jeremy C. Jones - Madison WI, US

Assignee:

Wisconsin Alumni Research Foundation - Madison WI

International Classification:

A61K 38/00
A61K 38/04
A61K 39/145
G01N 33/53

US Classification:

530326, 530327, 435 71, 4242061

Abstract:

The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.

US Patent:

20100040642, Feb 18, 2010

Filed:

Jun 15, 2009

Appl. No.:

12/484831

Inventors:

Curtis R. Brandt - Stoughton WI, US
Jeremy C. Jones - Madison WI, US

Assignee:

WISCONSIN ALUMNI RESEARCH FOUNDATION - Madison WI

International Classification:

A61K 39/145
A61P 37/04
A61P 31/12
A61P 31/16

US Classification:

4241861

Abstract:

The present disclosure generally relates to peptides having adjuvant properties, vaccines comprising the adjuvant peptides, and their use in prophylaxis or therapy for influenza. More particularly, the invention relates to adjuvant peptides that induce aggregation of influenza virus. The peptides can be included in influenza vaccines to increase the immune response to the vaccine.

US Patent:

20130190228, Jul 25, 2013

Filed:

Jan 24, 2012

Appl. No.:

13/357189

Inventors:

Curtis R. Brandt - Stoughton WI, US
Jeremy C. Jones - Madison WI, US

Assignee:

WISCONSIN ALUMNI RESEARCH FOUNDATION - Madison WI

International Classification:

C07K 7/08

US Classification:

514 37, 530326, 530327, 530324, 530328

Abstract:

The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.

US Patent:

20150246109, Sep 3, 2015

Filed:

Mar 9, 2015

Appl. No.:

14/642480

Inventors:

- Deerfield IL, US
Jorge E. Osorio - Mount Horeb WI, US
Timothy D. Powell - Fort Collins CO, US
Jeremy C. Jones - Memphis TN, US
Joseph N. Brewoo - Madison WI, US

International Classification:

A61K 39/145
C07K 14/005
A61K 39/12

Abstract:

Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.

US Patent:

20150184198, Jul 2, 2015

Filed:

Mar 11, 2015

Appl. No.:

14/645269

Inventors:

- Deerfield IL, US
Jorge E. Osorio - Mount Horeb WI, US
Timothy D. Powell - Fort Collins CO, US
Jeremy N. Jones - Memphis TN, US

International Classification:

C12N 15/86
A61K 39/145

Abstract:

Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions. In other embodiments, vaccine compositions are reported of use in a subject.